By Douglas Marchuk, Chair, Alliance to Cure Cavernous Malformation Scientific Advisory Board The National Institutes of Health (NIH) occasionally provides funding for a team of researchers, often from different institutions,…
Webinar recording now available. Recursion CEO Chris Gibson at our March 6 webinar explained the exciting results from Recursion’s Phase II SYCAMORE trial, the first industry-sponsored clinical trial for REC-994, …
Read Alliance to Cure’s Fall 2024 Newsletter Alliance to Cure’s Fall Newsletter highlights our progress towards better treatments and a cure for cavernous malformation. Read the newsletter to learn about…
Your generosity has made a difference! Get the full 2023 Impact Report here
The Alliance to Cure Cavernous Malformation, the leading global organization in urgent pursuit of improved care and a cure for the rare disease that causes seizures and strokes at…
